BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 15905203)

  • 1. Preferential induction of CYP1B1 by benzo[a]pyrene in human oral epithelial cells: impact on DNA adduct formation and prevention by polyphenols.
    Wen X; Walle T
    Carcinogenesis; 2005 Oct; 26(10):1774-81. PubMed ID: 15905203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of benzo[a]pyrene-activating enzymes and DNA binding in human bronchial epithelial BEAS-2B cells by methoxylated flavonoids.
    Tsuji PA; Walle T
    Carcinogenesis; 2006 Aug; 27(8):1579-85. PubMed ID: 16484233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5,7-Dimethoxyflavone downregulates CYP1A1 expression and benzo[a]pyrene-induced DNA binding in Hep G2 cells.
    Wen X; Walle UK; Walle T
    Carcinogenesis; 2005 Apr; 26(4):803-9. PubMed ID: 15661813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel methoxylated flavone inhibitors of cytochrome P450 1B1 in SCC-9 human oral cancer cells.
    Walle T; Walle UK
    J Pharm Pharmacol; 2007 Jun; 59(6):857-62. PubMed ID: 17637178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benzo[A]pyrene-induced oral carcinogenesis and chemoprevention: studies in bioengineered human tissue.
    Walle T; Walle UK; Sedmera D; Klausner M
    Drug Metab Dispos; 2006 Mar; 34(3):346-50. PubMed ID: 16381670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytochrome P450 1B1, a novel chemopreventive target for benzo[a]pyrene-initiated human esophageal cancer.
    Wen X; Walle T
    Cancer Lett; 2007 Feb; 246(1-2):109-14. PubMed ID: 16530937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of aryl hydrocarbon receptor transactivation and DNA adduct formation by CYP1 isoform-selective metabolic deactivation of benzo[a]pyrene.
    Endo K; Uno S; Seki T; Ariga T; Kusumi Y; Mitsumata M; Yamada S; Makishima M
    Toxicol Appl Pharmacol; 2008 Jul; 230(2):135-43. PubMed ID: 18372000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effects of chrysoeriol on DNA adduct formation with benzo[a]pyrene in MCF-7 breast cancer cells.
    Takemura H; Nagayoshi H; Matsuda T; Sakakibara H; Morita M; Matsui A; Ohura T; Shimoi K
    Toxicology; 2010; 274(1-3):42-8. PubMed ID: 20553787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benzo[a]pyrene-induced cytochrome P450 1A and DNA binding in cultured trout hepatocytes - inhibition by plant polyphenols.
    Tsuji PA; Walle T
    Chem Biol Interact; 2007 Aug; 169(1):25-31. PubMed ID: 17583686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue specific induction of cytochrome P450 (CYP) 1A1 and 1B1 in rat liver and lung following in vitro (tissue slice) and in vivo exposure to benzo(a)pyrene.
    Harrigan JA; McGarrigle BP; Sutter TR; Olson JR
    Toxicol In Vitro; 2006 Jun; 20(4):426-38. PubMed ID: 16198082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin activates the aryl hydrocarbon receptor yet significantly inhibits (-)-benzo(a)pyrene-7R-trans-7,8-dihydrodiol bioactivation in oral squamous cell carcinoma cells and oral mucosa.
    Rinaldi AL; Morse MA; Fields HW; Rothas DA; Pei P; Rodrigo KA; Renner RJ; Mallery SR
    Cancer Res; 2002 Oct; 62(19):5451-6. PubMed ID: 12359752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of CYP1A1 and CYP1B1 and formation of carcinogen-DNA adducts in normal human mammary epithelial cells treated with benzo[a]pyrene.
    Keshava C; Divi RL; Whipkey DL; Frye BL; McCanlies E; Kuo M; Poirier MC; Weston A
    Cancer Lett; 2005 Apr; 221(2):213-24. PubMed ID: 15808407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benzo[g,h,i]perylene synergistically transactivates benzo[a]pyrene-induced CYP1A1 gene expression by aryl hydrocarbon receptor pathway.
    Cherng SH; Lin P; Yang JL; Hsu SL; Lee H
    Toxicol Appl Pharmacol; 2001 Jan; 170(1):63-8. PubMed ID: 11141357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic polymorphisms in catalase and CYP1B1 determine DNA adduct formation by benzo(a)pyrene ex vivo.
    Schults MA; Chiu RK; Nagle PW; Wilms LC; Kleinjans JC; van Schooten FJ; Godschalk RW
    Mutagenesis; 2013 Mar; 28(2):181-5. PubMed ID: 23325794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of CYP1A1 and CYP1B1 in T-47D human breast cancer cells by benzo[a]pyrene is diminished by arsenite.
    Spink DC; Katz BH; Hussain MM; Spink BC; Wu SJ; Liu N; Pause R; Kaminsky LS
    Drug Metab Dispos; 2002 Mar; 30(3):262-9. PubMed ID: 11854143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral benzo[a]pyrene in Cyp1 knockout mouse lines: CYP1A1 important in detoxication, CYP1B1 metabolism required for immune damage independent of total-body burden and clearance rate.
    Uno S; Dalton TP; Dragin N; Curran CP; Derkenne S; Miller ML; Shertzer HG; Gonzalez FJ; Nebert DW
    Mol Pharmacol; 2006 Apr; 69(4):1103-14. PubMed ID: 16377763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzo[a]pyrene-induced toxicity: paradoxical protection in Cyp1a1(-/-) knockout mice having increased hepatic BaP-DNA adduct levels.
    Uno S; Dalton TP; Shertzer HG; Genter MB; Warshawsky D; Talaska G; Nebert DW
    Biochem Biophys Res Commun; 2001 Dec; 289(5):1049-56. PubMed ID: 11741297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quercetin inhibits benzo[a]pyrene-induced DNA adducts in human Hep G2 cells by altering cytochrome P-450 1A1 gene expression.
    Kang ZC; Tsai SJ; Lee H
    Nutr Cancer; 1999; 35(2):175-9. PubMed ID: 10693172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential induction of CYP1A1 and CYP1B1 by benzo[a]pyrene in oral squamous cell carcinoma cell lines and by tobacco smoking in oral mucosa.
    Chi AC; Appleton K; Henriod JB; Krayer JW; Marlow NM; Bandyopadhyay D; Sigmon RC; Kurtz DT
    Oral Oncol; 2009 Nov; 45(11):980-5. PubMed ID: 19576839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resveratrol, a natural aryl hydrocarbon receptor antagonist, protects lung from DNA damage and apoptosis caused by benzo[a]pyrene.
    Revel A; Raanani H; Younglai E; Xu J; Rogers I; Han R; Savouret JF; Casper RF
    J Appl Toxicol; 2003; 23(4):255-61. PubMed ID: 12884409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.